                         SEQUENCE LISTING

<110>  Novartis AG
 
<120>  Novel Cyclic Peptides And Use As Medicines

<130>  PAT055135-US-PSP

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  28
<212>  DNA
<213>  Synthetic Primer

<400>  1
gggcgcgcca tggcttccaa ggtgtacg                                          28


<210>  2
<211>  27
<212>  DNA
<213>  Synthetic Primer

<400>  2
cgcggccgct cagaagaact cgtcaag                                           27


<210>  3
<211>  39
<212>  DNA
<213>  Synthetic Primer

<400>  3
ctcaaactca ctccaatagc tgccgctggc cggctggac                              39


<210>  4
<211>  39
<212>  DNA
<213>  Synthetic Primer

<400>  4
gtccagcggg ccagcggcag ctattggagt gagtttgag                              39


<210>  5
<211>  28
<212>  DNA
<213>  Synthetic Primer

<400>  5
gggcgcgcca tggcttccaa ggtgtacg                                          28


<210>  6
<211>  27
<212>  DNA
<213>  Synthetic Primer

<400>  6
cgcggccgct cagaagaact cgtcaag                                           27


